CID 139350422

Zanzalintinib

Structural Information

Molecular Formula
C29H25FN4O5
SMILES
CNC(=O)C1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
InChI
InChI=1S/C29H25FN4O5/c1-31-26(35)22-15-21-23(16-25(22)38-2)32-14-11-24(21)39-20-9-7-19(8-10-20)34-28(37)29(12-13-29)27(36)33-18-5-3-17(30)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,35)(H,33,36)(H,34,37)
InChIKey
JSPCKALGNNVYOO-UHFFFAOYSA-N
Compound name
1-N'-(4-fluorophenyl)-1-N-[4-[7-methoxy-6-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

78
Patents

528.1809 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 529.18818 225.3
[M+Na]+ 551.17012 238.0
[M+NH4]+ 546.21472 231.1
[M+K]+ 567.14406 231.0
[M-H]- 527.17362 237.8
[M+Na-2H]- 549.15557 236.2
[M]+ 528.18035 231.6
[M]- 528.18145 231.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe